Constellation Brands (STZ) is showing mixed signals with several notable highlights. The company has faced criticism from Jim Cramer, who termed it a terrible stock. However, others have highlighted Constellation's growth potential such as the surge in options activity. Analysts have also revealed that Buffett has a $3.9B stake in the company. Tariffs and a dip in beer demand are affecting STZ's performance. Predicted EPS growth may reshape the company's long-term value proposition.
Hispanic market pressures seem to be easing. Estimates on earnings and key metrics have Wall Street's attention. UBS has increased the price target on STZ after the Q1 2025 earnings release. However, there are concerns that the shares may have run too fast too soon. A Stanford executive sold his Constellation stock in a major move, but the company's board chair made a bold stock purchase.
The company's Q1 Earnings and Revenue missed estimates causing the stock to slip by 1%. The beer gains generated by STZ have offset its wine decline, but there are predictions of weak performance persisting. Still, some believe Constellation is a good buy with room to run, even with tariffs.
Constellation Brands STZ News Analytics from Thu, 27 Mar 2025 07:00:00 GMT to Sat, 23 Aug 2025 05:59:20 GMT -
Rating 0.5
- Innovation 5
- Information 4
- Rumor -5
